Position in HRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,787
-$2,029,004 QoQ
Shares Held
120,435
-95.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. HRTX ranks #204 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,787 | 120,435 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,080,791 | 2,600,990 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,906,031 | 3,004,640 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,891,499 | 3,088,492 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,624,618 | 3,200,299 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,569,633 | 2,986,197 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,697,270 | 3,723,706 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,725,506 | 4,384,677 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,521,812 | 3,863,375 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,465,277 | 2,695,046 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,194,694 | 1,290,997 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $252,630 | 245,273 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $404,792 | 348,960 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,088,833 | 721,082 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,967,700 | 787,080 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,796,188 | 899,571 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,505,799 | 1,614,982 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,635,789 | 2,034,229 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,329,982 | 1,350,491 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,307,320 | 1,431,929 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $30,483,607 | 1,964,150 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $35,781,791 | 2,207,390 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $47,871,254 | 2,261,278 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $31,013,309 | 2,092,666 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $31,162,281 | 2,118,442 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $27,296,708 | 2,325,103 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||